Valeant Shares On A Slide, To Host Emergency Board Meeting
October 23, 2015 at 18:20 PM EDT
Valeant Pharmaceuticals shares have been falling persistently over the last week. The company has hit a rough patch ever since it came under the spotlight for increasing the prices of two drugs (Nitropress and Isuprel) in September 2015.
